Related references
Note: Only part of the references are listed.AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol
Shuyang Chen et al.
CELL CYCLE (2015)
Nitrogen Regulates AMPK to Control TORC1 Signaling
Elizabeth Davie et al.
CURRENT BIOLOGY (2015)
Galbanic acid inhibits HIF-1α expression via EGFR/HIF-1α pathway in cancer cells
Morteza Eskandani et al.
FITOTERAPIA (2015)
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
Gregg L. Semenza
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Ionizing radiation activates PERK/eIF2α/ATF4 signaling via ER stress-independent pathway in human vascular endothelial cells
Eun Ju Kim et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
Shaojun Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
Andrew L. Doedens et al.
NATURE IMMUNOLOGY (2013)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming
Shuo Qie et al.
CELL CYCLE (2012)
Two mutations impair the stability and function of ubiquitin-activating enzyme (E1)
Taotao Lao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells Modulation of cellular signals regulating cell cycle and survival
Toran Sanli et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Hiroshi Harada et al.
NATURE COMMUNICATIONS (2012)
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Johannes Schoedel et al.
BLOOD (2011)
Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue
Sergio Rey et al.
BLOOD (2011)
BAY 87-2243 targets hypoxia-induced activation and stabilization of HIF-1α: A novel approach to overcome resistance mechanisms in cancer therapy
Kerstin Berhoerster et al.
CANCER RESEARCH (2011)
Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Z. Zhang et al.
CURRENT MEDICINAL CHEMISTRY (2011)
HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
Hao Geng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors
Shuyang Chen et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients
Philippe Metellus et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Hypoxia Triggers AMPK Activation through Reactive Oxygen Species-Mediated Activation of Calcium Release-Activated Calcium Channels
Paul T. Mungai et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
Kenneth K. W. To et al.
MOLECULAR CANCER RESEARCH (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
AMPK regulates metabolism and survival in response to ionizing radiation
Vanessa E. Zannella et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells
Meng Meng et al.
CELL CYCLE (2010)
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
Keiyo Takubo et al.
CELL STEM CELL (2010)
The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma (Publication with Expression of Concern. See vol. 25, pg. 4194, 2019)
Daniel C. Cho et al.
CLINICAL CANCER RESEARCH (2010)
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
Jiangbin Ye et al.
EMBO JOURNAL (2010)
ER stress induced by ionising radiation in IEC-6 cells
Bo Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2010)
IONIZING RADIATION ACTIVATES AMP-ACTIVATED KINASE (AMPK): A TARGET FOR RADIOSENSITIZATION OF HUMAN CANCER CELLS
Toran Sanli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
Weibo Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
JNK Contributes to Hif-1 alpha Regulation in Hypoxic Neurons
Xanthi Antoniou et al.
MOLECULES (2010)
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Mikko Taipale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Parameters of Protection Against Ultraviolet Radiation-induced Skin Cell Damage
Cong Cao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
被撤回的出版物: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells (Retracted article. See vol. 119, 2022)
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
Sergio Rey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
AMP-activated protein kinase activity during metabolic rate depression in the hypoxic goldfish, Carassius auratus
Lindsay A. Jibb et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Differential Gene Signatures in Rat Mammary Tumors Induced by DMBA and Those Induced by Fractionated γ Radiation
Hae-June Lee et al.
RADIATION RESEARCH (2008)
Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α
Zheqing Cai et al.
CARDIOVASCULAR RESEARCH (2008)
Hypoxia signalling through mTOR and the unfolded protein response in cancer
Bradly G. Wouters et al.
NATURE REVIEWS CANCER (2008)
Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia
Marta Bosch-Marce et al.
CIRCULATION RESEARCH (2007)
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells
Adrian Staab et al.
BMC CANCER (2007)
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
Sven A. Lang et al.
CLINICAL CANCER RESEARCH (2007)
Evaluation of HIF-1 inhibitors as anticancer agents
Gregg L. Semenza
DRUG DISCOVERY TODAY (2007)
Detection and characterization of tumor hypoxia using pO2 histography
Peter Vaupel et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
Ying Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hypoxia-inducible factors, stem cells, and cancer
Brian Keith et al.
CELL (2007)
Targeting the ubiquitin-proteasome pathway in cancer therapy
Yuki Ishii et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano et al.
NATURE (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Effects of histone deacetylase inhibitors on HIF-1
Dongming Liang et al.
CELL CYCLE (2006)
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
David Z. Qian et al.
CANCER RESEARCH (2006)
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Rosa Bernardi et al.
NATURE (2006)
Proteasome inhibitor drugs on the rise
Claudio A. P. Joazeiro et al.
CANCER RESEARCH (2006)
Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain
Stefan Kaluz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
5′-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments
Keith R. Laderoute et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of angiogenesis by hypoxia-inducible factor 1
Kiichi Hirota et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
The PERK/elF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth
Diane R. Fels et al.
CANCER BIOLOGY & THERAPY (2006)
Metallothioneins and resistance to cisplatin and radiation in prostate cancer
David J. Smith et al.
UROLOGY (2006)
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α
DM Fath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CCl-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF signaling
Xiaolin Wan et al.
NEOPLASIA (2006)
Development of novel therapeutic strategies that target HIF-1
GL Semenza
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis
M Bazzaro et al.
CANCER RESEARCH (2006)
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
N Pore et al.
CANCER RESEARCH (2006)
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α
XG Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Radiation and new molecular agents part 1: Targeting ATM-ATR checkpoints, DNA repair, and the proteasome
A Choudhury et al.
SEMINARS IN RADIATION ONCOLOGY (2006)
Regulation of dendritic morphogenesis by Ras-PI3K-Akt mTOR and Ras-MAPK signaling pathways
V Kumar et al.
JOURNAL OF NEUROSCIENCE (2005)
Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia
TH Patel et al.
CARDIOVASCULAR RESEARCH (2005)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1α accumulation and activity by disrupting microtubule function
D Escuin et al.
CANCER RESEARCH (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
J Fang et al.
FASEB JOURNAL (2005)
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
DJ Manalo et al.
BLOOD (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents
Y Miyata
CURRENT PHARMACEUTICAL DESIGN (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development
SR Chang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Intrasteric control of AMPK via the gamma(1) subunit AMP allosteric regulatory site
J Adams et al.
PROTEIN SCIENCE (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1 alpha stabilization
DM Katschinski et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
BD Kelly et al.
CIRCULATION RESEARCH (2003)
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
M Hirsilä et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
JB Brugarolas et al.
CANCER CELL (2003)
Geldanamycin inhibits migration of glioma cells in vitro:: A potential role for hypoxia-inducible factor (HIF-1α) in glioma cell invasion
D Zagzag et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?
RW Johnstone et al.
CANCER CELL (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery
WB Pratt et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
YM Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway
N Kimura et al.
GENES TO CELLS (2003)
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Akt regulates growth by directly phosphorylating Tsc2
CJ Potter et al.
NATURE CELL BIOLOGY (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP
NL Sang et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
Enzymatic activity associated with class IIHDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR
W Fischle et al.
MOLECULAR CELL (2002)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
Histone deacetylase inhibitors as new cancer drugs
PA Marks et al.
CURRENT OPINION IN ONCOLOGY (2001)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Identification of a signal-responsive nuclear export sequence in class II histone deacetylases
TA McKinsey et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
